Skip to main content
Back to 8VC

8VC's Therapeutics Portfolio

Browse 19 Therapeutics companies funded by 8VC. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
19
Total Funding in Therapeutics
$1.6B

Therapeutics Portfolio Companies (19)

Export
BiotechnologyTherapeutics

Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.

Cambridge, United States
September 2022
$75.0M
Series A

Founder Contacts

30,000+ verified contacts

Health CareMental HealthmHealthPersonal HealthTherapeuticsWellness

Mindstrong is a virtual mental health platform.

Menlo Park, United States
September 2022
$250K
Grant

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedicalTherapeutics

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

San Mateo, United States
July 2022
$75.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Acepodia is a therapeutics company that employs flexible therapeutic design to treat cancer.

Alameda, United States
June 2023
$100.0M
Series D

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceOncologyTherapeutics

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

South San Francisco, United States
May 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsTherapeutics

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

Philadelphia, United States
May 2026
$43.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceuticalTherapeutics

SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.

San Francisco, United States
May 2025
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.

Cambridge, United States
May 2026
$122.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.

Waltham, United States
April 2026
$40.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyTherapeutics

Amber Therapeutics develops the next-generation of bioelectrical therapies.

London, United Kingdom
March 2026
Non-equity Assistance

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

San Francisco, United States
February 2026
$150.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceManufacturingMedicalTherapeutics

Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.

South San Francisco, United States
January 2026
$257.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Sonoma Biotherapeutics develops engineered regulatory T-cell (Treg) therapies to treat autoimmune and inflammatory diseases.

South San Francisco, United States
November 2025
$300K
Grant

Founder Contacts

30,000+ verified contacts

AnalyticsArtificial Intelligence (AI)BiotechnologyMachine LearningTherapeutics

Immunai is a biotech company that provides mapping and reprogramming immunology, machine learning, and software engineering.

New York, United States
October 2021
$215.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics.

Menlo Park, United States
October 2022
$77.3M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Ness Ziona, Israel
December 2025
$3.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

Redwood City, United States
November 2025
$350.0M
Post Ipo Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

South San Francisco, United States
May 2025
$1.0M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareManufacturingOncologyPharmaceuticalTherapeuticsWellness

Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.

Boston, United States
December 2024
$48.1M
Series A

Founder Contacts

30,000+ verified contacts

Explore 8VC's Full Portfolio

View all companies funded by 8VC across every industry and funding stage.

View Full 8VC Portfolio